Corticosteroid related adverse events · Patients with active Crohn's disease
Budesonide 9 mg showed no clear difference in corticosteroid related adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Overall survival Hazard ratio · patients with resectable thoracic esophageal cancer
The intervention probably leads to lower overall survival Hazard ratio (moderate certainty).
1 finding from 1 review
Intervention not reported
Complete resection (R0) Histology · patients with resectable thoracic esophageal cancer
The intervention probably leads to higher complete resection (R0) Histology (moderate certainty).
1 finding from 1 review
Intervention not reported
Local‐regional recurrence Radiology · patients with resectable thoracic esophageal cancer
The intervention showed no clear difference in local‐regional recurrence Radiology (moderate certainty).
1 finding from 1 review
Intervention not reported
Distant recurrence Radiology · patients with resectable thoracic esophageal cancer
The intervention showed no clear difference in distant recurrence Radiology (moderate certainty).
1 finding from 1 review
Intervention not reported
Any complication Clinical · patients with resectable thoracic esophageal cancer
The intervention showed no clear difference in any complication Clinical (moderate certainty).
1 finding from 1 review
Intervention not reported
Postoperative death Clinical · patients with resectable thoracic esophageal cancer
The intervention showed no clear difference in postoperative death Clinical (low certainty).
1 finding from 1 review
Intervention not reported
Anastomotic leaks Clinical/radiology · patients with resectable thoracic esophageal cancer
The intervention showed no clear difference in anastomotic leaks Clinical/radiology (moderate certainty).
1 finding from 1 review
Intervention not reported
Overall survival (surviving rates) · patients with resectable disease
1 finding from 1 review
Intervention not reported
Postoperative mortality (within 30 days from surgery) · patients with resectable disease
1 finding from 1 review
Intervention not reported
Overall survival (surviving rates) · patients with resectable disease
The intervention showed no clear difference in overall survival (surviving rates) (low certainty).
1 finding from 1 review
Intervention not reported
Disease specific survival (surviving rates) · patients with resectable disease
The intervention probably leads to lower disease specific survival (surviving rates) (moderate certainty).
1 finding from 1 review
Intervention not reported
Disease free survival (surviving rates) · patients with resectable disease
The intervention showed no clear difference in disease free survival (surviving rates) (moderate certainty).
1 finding from 1 review
Intervention not reported
Postoperative mortality (within 30 days from surgery) · patients with resectable disease
The intervention leads to higher postoperative mortality (within 30 days from surgery) (high certainty).
1 finding from 1 review
(< 1 year) · Patients with gastro‐oesophageal reflux disease (GORD) in adults
1 finding from 1 review
(1 to 5 years) · Patients with gastro‐oesophageal reflux disease (GORD) in adults
1 finding from 1 review
Adverse events · Patients with gastro‐oesophageal reflux disease (GORD) in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · Patients with gastro‐oesophageal reflux disease (GORD) in adults
It is very uncertain whether laparoscopic fundoplication changes serious adverse events compared with medical management (very low certainty).
1 finding from 1 review
Dysphagia · Patients with gastro‐oesophageal reflux disease (GORD) in adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
(5 years or more) · Patients with gastro‐oesophageal reflux disease (GORD) in adults
It is very uncertain whether laparoscopic fundoplication changes (5 years or more) compared with medical management (very low certainty).
1 finding from 1 review